Stroke

Article	Citations
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association	1471
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association	550
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities	277
Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke	228
Acute Ischemic Stroke and COVID-19	217
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association	184
Tenecteplase Thrombolysis for Acute Ischemic Stroke	122
Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association	114
Clonal Hematopoiesis Is Associated With Higher Risk of Stroke	110
Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword	103
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke	100
Cancer and Embolic Stroke of Undetermined Source	99
Inflammation and Stroke Risk: A New Target for Prevention	97
Multimodal Predictive Modeling of Endovascular Treatment Outcome for Acute Ischemic Stroke Using Machine-Learning	97
Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes: Consensus Recommendations From Stroke Therapy Academic Industry Roundtable XI	95
Top Priorities for Cerebroprotective Studies—A Paradigm Shift: Report From STAIR XI	90
Large and Small Cerebral Vessel Involvement in Severe COVID-19	89
Interventions Targeting Racial/Ethnic Disparities in Stroke Prevention and Treatment	87
Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment	86
Projected Global Trends in Ischemic Stroke Incidence, Deaths and Disability-Adjusted Life Years From 2020 to 2030	85
Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China	85
Neutrophil-to-Lymphocyte Ratio Predicts Cerebral Edema and Clinical Worsening Early After Reperfusion Therapy in Stroke	83
Considerations in Addressing Social Determinants of Health to Reduce Racial/Ethnic Disparities in Stroke Outcomes in the United States	83
Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association/American Stroke Association	80
Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions	78

Comprehensive Stroke Care and Outcomes	78
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin	74
Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis	74
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study	73
Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views	72
Vessel Wall Magnetic Resonance Imaging Biomarkers of Symptomatic Intracranial Atherosclerosis	72
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease	72
Recommendations for Regional Stroke Destination Plans in Rural, Suburban, and Urban Communities From the Prehospital Stroke System of Care Consensus Conference: A Consensus Statement From the American	70
Chronic Kidney Disease and Cerebrovascular Disease	68
Poststroke Cognitive Impairment Negatively Impacts Activity and Participation Outcomes	67
Immunodepression, Infections, and Functional Outcome in Ischemic Stroke	66
CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage	66
Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke	65
Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events	64
Intracerebral Hemorrhage Incidence, Mortality, and Association With Oral Anticoagulation Use	63
Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia	62
Early Infarct Growth Rate Correlation With Endovascular Thrombectomy Clinical Outcomes	62
Good Clinical Outcome Decreases With Number of Retrieval Attempts in Stroke Thrombectomy	62
Early Brain Injury After Subarachnoid Hemorrhage: Incidence and Mechanisms	61
Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage	61
Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke	61
Reperfusion Without Functional Independence in Late Presentation of Stroke With Large Vessel Occlusion	61
Acute Cerebrovascular Events With COVID-19 Infection	60
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial	60
Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study	60
Mismatch Profile Influences Outcome After Mechanical Thrombectomy	59
Collateral Circulation in Thrombectomy for Stroke After 6 to 24 Hours in the DAWN Trial	58
Ischemic Stroke Occurs Less Frequently in Patients With COVID-19	58
Analysis of Nationwide Stroke Patient Care in Times of COVID-19 Pandemic in Germany	58
Cerebroprotection for Acute Ischemic Stroke: Looking Ahead	57
Endovascular Therapy of Anterior Circulation Tandem Occlusions	57
New Insights Into Cerebrovascular Pathophysiology and Hypertension	56
Dynamic Prevalence of Sleep Disorders Following Stroke or Transient Ischemic Attack	56
Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy	56
Endothelial Dysfunction in the Brain	56
Sleep Duration and Stroke	56
Stroke Imaging Selection Modality and Endovascular Therapy Outcomes in the Early and Extended Time Windows	56
Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review–Based, Individual Participant Data Network Meta-Analysis	56
Female Stroke	55
Qualitative and Quantitative Wall Enhancement on Magnetic Resonance Imaging Is Associated With Symptoms of Unruptured Intracranial Aneurysms	55
Stroke Incidence by Sex Across the Lifespan	55
Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke	54
Posterior National Institutes of Health Stroke Scale Improves Prognostic Accuracy in Posterior Circulation Stroke	53
Bridging Thrombolysis Achieved Better Outcomes Than Direct Thrombectomy After Large Vessel Occlusion	53
Favorable Venous Outflow Profiles Correlate With Favorable Tissue-Level Collaterals and Clinical Outcome	53
Predicting Infarct Core From Computed Tomography Perfusion in Acute Ischemia With Machine Learning: Lessons From the ISLES Challenge	52
Sex Differences in Presentation of Stroke: A Systematic Review and Meta-Analysis	52
Long-Term Cognitive Decline After Stroke: An Individual Participant Data Meta-Analysis	51
Ten-Year Trend in Age, Sex, and Racial Disparity in tPA (Alteplase) and Thrombectomy Use Following Stroke in the United States	51
Thrombectomy Versus Combined Thrombolysis and Thrombectomy in Patients With Acute Stroke	51

Lipid-Lowering Therapy and Hemorrhagic Stroke Risk	51
Clinically Ineffective Reperfusion After Endovascular Therapy in Acute Ischemic Stroke	50
Depression, Anxiety, and Suicide After Stroke: A Narrative Review of the Best Available Evidence	50
Cerebral Collateral Circulation in the Era of Reperfusion Therapies for Acute Ischemic Stroke	50
Contrast-Induced Encephalopathy After Endovascular Thrombectomy for Acute Ischemic Stroke	50
Ischemic Core Overestimation on Computed Tomography Perfusion	49
SARS-CoV-2 and Stroke Characteristics	49
Mechanical Characterization of Thrombi Retrieved With Endovascular Thrombectomy in Patients With Acute Ischemic Stroke	49
Adherence to the EAT-Lancet Diet and Risk of Stroke and Stroke Subtypes: A Cohort Study	49
High Admission Glucose Is Associated With Poor Outcome After Endovascular Treatment for Ischemic Stroke	49
Adiposity and Outcome After Ischemic Stroke	48
The Neurovasculome: Key Roles in Brain Health and Cognitive Impairment: A Scientific Statement From the American Heart Association/American Stroke Association	48
Microvascular Dysfunction in Blood-Brain Barrier Disruption and Hypoperfusion Within the Infarct Posttreatment Are Associated With Cerebral Edema	48
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association	48
Under-Enrollment of Women in Stroke Clinical Trials	48
Young Women Had More Strokes Than Young Men in a Large, United States Claims Sample	47
Mechanical Thrombectomy in Medium Vessel Occlusions	47
Inhibition of EZH2 (Enhancer of Zeste Homolog 2) Attenuates Neuroinflammation via H3k27me3/SOCS3/TRAF6/NF-κB (Trimethylation of Histone 3 Lysine 27/Suppressor of Cytokine Signaling 3/Tumor Necrosis Fa	46
Comparison of Large Animal Models for Acute Ischemic Stroke: Which Model to Use?	46
Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Trans	46
Circadian Biology and Stroke	45
Prediction of Independent Walking in People Who Are Nonambulatory Early After Stroke	45
Genetics of Intracranial Aneurysms	45
Stroke Care in the United Kingdom During the COVID-19 Pandemic	45
Endovascular Versus Medical Management of Posterior Cerebral Artery Occlusion Stroke: The PLATO Study	45
Predictors of Poststroke Aphasia Recovery	45
Advancing Stroke Recovery Through Improved Articulation of Nonpharmacological Intervention Dose	45
Mendelian Randomization Studies in Stroke: Exploration of Risk Factors and Drug Targets With Human Genetic Data	44
Qualitative Study of Chinese Stroke Caregivers’ Caregiving Experience During the COVID-19 Pandemic	44
Atrial Fibrillation Following Patent Foramen Ovale Closure	44
Studying Stroke Thrombus Composition After Thrombectomy: What Can We Learn?	44
Neuroinflammation, Stem Cells, and Stroke	44
Thrombectomy in Extensive Stroke May Not Be Beneficial and Is Associated With Increased Risk for Hemorrhage	43
Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection	43
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6	43
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia	43
Values of Baseline Posterior Circulation Acute Stroke Prognosis Early Computed Tomography Score for Treatment Decision of Acute Basilar Artery Occlusion	43
Quantitative Morphology of Cerebral Thrombi Related to Intravital Contraction and Clinical Features of Ischemic Stroke	42
Access to Mechanical Thrombectomy for Ischemic Stroke in the United States	42
Switching to Tenecteplase for Stroke Thrombolysis	42
Evidence-Based Disparities in Stroke Care Metrics and Outcomes in the United States: A Systematic Review	42
Decompressive Hemicraniectomy for Large Hemispheric Strokes	42
Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly	42
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials	42
Endovascular Therapy for Stroke due to Basilar Artery Occlusion	41
Hospitalizations for Stroke in France During the COVID-19 Pandemic Before, During, and After the National Lockdown	41
Impact of Age and Alberta Stroke Program Early Computed Tomography Score 0 to 5 on Mechanical Thrombectomy Outcomes: Analysis From the STRATIS Registry	41
Early Brain Imaging Shows Increased Severity of Acute Ischemic Strokes With Large Vessel Occlusion in COVID-19 Patients	41
Stroke Acute Management and Outcomes During the COVID-19 Outbreak	41
Unique Subtype of Microglia in Degenerative Thalamus After Cortical Stroke	41
Acute Ischemic Stroke in Patients With COVID-19	41
Stenting and Angioplasty in Neurothrombectomy: Matched Analysis of Rescue Intracranial Stenting Versus Failed Thrombectomy	41
Intravenous Tirofiban Infusion After Angioplasty and Stenting in Intracranial Atherosclerotic Stenosis-Related Stroke	41
Blood Pressure Management for Ischemic Stroke in the First 24 Hours	40
Reperfusion Injury Is Associated With Poor Outcome in Patients With Recanalization After Thrombectomy	40
Sex, Age, and Socioeconomic Differences in Nonfatal Stroke Incidence and Subsequent Major Adverse Outcomes	40
Detection and Quantification of Symptomatic Atherosclerotic Plaques With High-Resolution Imaging in Cryptogenic Stroke	40
The Story of Intracerebral Hemorrhage	40
Reperfusion Therapy Frequency and Outcomes in Mild Ischemic Stroke in the United States	40
Clinical and Imaging Indicators of Hemorrhagic Transformation in Acute Ischemic Stroke After Endovascular Thrombectomy	40
Sex Differences in Cerebral Aneurysms and Subarachnoid Hemorrhage	40
Care of the Patient With Acute Ischemic Stroke (Posthyperacute and Prehospital Discharge): Update to 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement From the American Hear	39
Number of Retrieval Attempts Rather Than Procedure Time Is Associated With Risk of Symptomatic Intracranial Hemorrhage	39
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study	39
Efficacy of Intravenous Mesenchymal Stem Cells for Motor Recovery After Ischemic Stroke: A Neuroimaging Study	39
Large Vessel Occlusion Stroke due to Intracranial Atherosclerotic Disease: Identification, Medical and Interventional Treatment, and Outcomes	38
Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association	38
Cerebral Edema in Patients With Large Hemispheric Infarct Undergoing Reperfusion Treatment: A HERMES Meta-Analysis	38
Obesity and Risk for First Ischemic Stroke Depends on Metabolic Syndrome: The HUNT Study	38
Electroencephalography Might Improve Diagnosis of Acute Stroke and Large Vessel Occlusion	38
Modifiable Lifestyle Factors and Risk of Stroke	38
IL33 (Interleukin 33)/ST2 (Interleukin 1 Receptor-Like 1) Axis Drives Protective Microglial Responses and Promotes White Matter Integrity After Stroke	38
Aβ (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts	37
Postischemic Neuroprotection Associated With Anti-Inflammatory Effects by Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles in Aged Mice	37
Early Recanalization With Alteplase in Stroke Because of Large Vessel Occlusion in the ESCAPE Trial	37
Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia	37
Predicting 90-Day Outcome After Thrombectomy: Baseline-Adjusted 24-Hour NIHSS Is More Powerful Than NIHSS Score Change	37
Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation	37
Tandem Lesions in Anterior Circulation Stroke	37
A Robust Deep Learning Segmentation Method for Hematoma Volumetric Detection in Intracerebral Hemorrhage	36

Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease	36
Sirtuin 5-Mediated Lysine Desuccinylation Protects Mitochondrial Metabolism Following Subarachnoid Hemorrhage in Mice	36
Practical “1-2-3-4-Day” Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study	36
Carotid Artery Plaque Calcifications: Lessons From Histopathology to Diagnostic Imaging	36
Imaging Markers of Brain Frailty and Outcome in Patients With Acute Ischemic Stroke	36
Utility of the Hospital Frailty Risk Score Derived From Administrative Data and the Association With Stroke Outcomes	36
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome	36
Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy	36
Safety and Outcome of Carotid Dissection Stenting During the Treatment of Tandem Occlusions	35
Role of Inflammatory Processes in Hemorrhagic Stroke	35
Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients	35
Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke	35
Prospective Observational Cohort Study of Tenecteplase Versus Alteplase in Routine Clinical Practice	35
Priming Intermittent Theta Burst Stimulation for Hemiparetic Upper Limb After Stroke: A Randomized Controlled Trial	35
Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients	34
Ischemic Cerebral Endothelial Cell–Derived Exosomes Promote Axonal Growth	34
Blood Pressure Management After Intracerebral and Subarachnoid Hemorrhage: The Knowns and Known Unknowns	34
Functional Investigation of Meningeal Lymphatic System in Experimental Intracerebral Hemorrhage	34
Distal Medium Vessel Occlusions Can Be Accurately and Rapidly Detected Using Tmax Maps	34
Iron Deposition in the Brain After Aneurysmal Subarachnoid Hemorrhage	34
The Problem of Restrictive Thrombectomy Trial Eligibility Criteria	34
Invasive Multimodal Neuromonitoring in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review	34
Prevalence and Prognostic Significance of Malnutrition Risk in Patients With Acute Ischemic Stroke: Results From the Third China National Stroke Registry	34
Moyamoya Disease Susceptibility Gene RNF213 Regulates Endothelial Barrier Function	34
Cost-Effectiveness of Tenecteplase Before Thrombectomy for Ischemic Stroke	34
Hippocampal Vascular Supply and Its Role in Vascular Cognitive Impairment	34
Transcranial Direct Current Stimulation Enhances Neuroplasticity and Accelerates Motor Recovery in a Stroke Mouse Model	34
Comparative Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients	34
Dysbiosis of Gut Microbiome Is Associated With Rupture of Cerebral Aneurysms	33
Ambient Air Pollution and Stroke: An Updated Review	33
Mobile Stroke Units: Evidence, Gaps, and Next Steps	33
Perfusion Imaging for Endovascular Thrombectomy in Acute Ischemic Stroke Is Associated With Improved Functional Outcomes in the Early and Late Time Windows	33
Circulatory MicroRNAs as Potential Biomarkers for Stroke Risk	32
Prediction of Outcome and Endovascular Treatment Benefit: Validation and Update of the MR PREDICTS Decision Tool	32
Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments	32
Direct, Indirect, and Combined Extracranial-to-Intracranial Bypass for Adult Moyamoya Disease: An Updated Systematic Review and Meta-Analysis	32
Time to Evacuation and Functional Outcome After Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation	32
Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor–Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care	32
Admission Blood Pressure in Relation to Clinical Outcomes and Successful Reperfusion After Endovascular Stroke Treatment	32
Drugs Associated With Ischemic Stroke	32
Remnant Cholesterol Variability and Incident Ischemic Stroke in the General Population	32
Mast Cell Promotes the Development of Intracranial Aneurysm Rupture	32
Accuracy of Automated Computer-Aided Diagnosis for Stroke Imaging: A Critical Evaluation of Current Evidence	32
Sex Differences in Short-Term and Long-Term Outcomes Among Patients With Acute Ischemic Stroke in China	31
Thromboinflammation in Brain Ischemia: Recent Updates and Future Perspectives	31
Endovascular Treatment and Thrombolysis for Acute Ischemic Stroke in Patients With Premorbid Disability or Dementia: A Scientific Statement From the American Heart Association/American Stroke Associat	31
Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists	31
Different Predictive Factors for Early Neurological Deterioration Based on the Location of Single Subcortical Infarction	31
Acute Viral Illnesses and Ischemic Stroke	31
Temporal Profile of Pneumonia After Stroke	31
Mobile Interventional Stroke Team Model Improves Early Outcomes in Large Vessel Occlusion Stroke	31
New Class of Radially Adjustable Stentrievers for Acute Ischemic Stroke	31
Excess Cerebrovascular Mortality in the United States During the COVID-19 Pandemic	31
TREM (Triggering Receptor Expressed on Myeloid Cells)-1 Inhibition Attenuates Neuroinflammation via PKC (Protein Kinase C) δ/CARD9 (Caspase Recruitment Domain Family Member 9) Signaling Pathway After	31
D-Dimer as Predictor of Large Vessel Occlusion in Acute Ischemic Stroke	31
Age at Menopause and Risk of Ischemic and Hemorrhagic Stroke	31
Intravenous Hydrogen Therapy With Intracisternal Magnesium Sulfate Infusion in Severe Aneurysmal Subarachnoid Hemorrhage	31
Secondary Medium Vessel Occlusions	31
Baseline Cognitive Impairment in Patients With Asymptomatic Carotid Stenosis in the CREST-2 Trial	31
Greater Adherence to Secondary Prevention Medications Improves Survival After Stroke or Transient Ischemic Attack: A Linked Registry Study	31
Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations	31
Sex-Specific Immune Responses in Stroke	31
Early Deterioration, Hematoma Expansion, and Outcomes in Deep Versus Lobar Intracerebral Hemorrhage: The FAST Trial	30
Sex Differences in Stroke Care and Outcome 2005–2018	30
Oral Carriage of Streptococcus mutans Harboring the cnm Gene Relates to an Increased Incidence of Cerebral Microbleeds	30
Intracerebral Hemorrhage in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy	30
Noncontrast Computed Tomography e-Stroke Infarct Volume Is Similar to RAPID Computed Tomography Perfusion in Estimating Postreperfusion Infarct Volumes	30
Sex Difference and Rupture Rate of Intracranial Aneurysms: An Individual Patient Data Meta-Analysis	30
Fibrin and Platelet-Rich Composition in Retrieved Thrombi Hallmarks Stroke With Active Cancer	30
Intracerebral Hemorrhage in Patients With COVID-19	30
Care of the Patient With Acute Ischemic Stroke (Prehospital and Acute Phase of Care): Update to the 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement From the American Heart	30
Predictors for Failure of Early Neurological Improvement After Successful Thrombectomy in the Anterior Circulation	30
Maintenance of Acute Stroke Care Service During the COVID-19 Pandemic Lockdown	30
Choline Pathway Nutrients and Metabolites and Cognitive Impairment After Acute Ischemic Stroke	30
Microglial Calcium Waves During the Hyperacute Phase of Ischemic Stroke	30
Changes in Stroke Hospital Care During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis	29
Systematic Review of Sex Differences in Ischemic Strokes Among Young Adults: Are Young Women Disproportionately at Risk?	29
Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment	29
The Stroke Preclinical Assessment Network: Rationale, Design, Feasibility, and Stage 1 Results	29
Aspiration Versus Stent Retriever Thrombectomy for Posterior Circulation Stroke	29
Which Acute Ischemic Stroke Patients Are Fast Progressors?	29
Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation	29
Risk Factors and Causes of Ischemic Stroke in 1322 Young Adults	29
Neuropathology of Vascular Brain Health: Insights From Ex Vivo Magnetic Resonance Imaging–Histopathology Studies in Cerebral Small Vessel Disease	29
Proteomic Profiling of Exosomes From Hemorrhagic Moyamoya Disease and Dysfunction of Mitochondria in Endothelial Cells	29
Optimal Medical Management of Asymptomatic Carotid Stenosis	29
Association of Serum IL-6 (Interleukin 6) With Functional Outcome After Intracerebral Hemorrhage	29
Automated Electronic Phenotyping of Cardioembolic Stroke	28
Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk	28
Thrombectomy Complications in Large Vessel Occlusions: Incidence, Predictors, and Clinical Impact in the ETIS Registry	28
Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population	28
Glenzocimab: A GPVI (Glycoprotein VI)-Targeted Potential Antiplatelet Agent for the Treatment of Acute Ischemic Stroke	28
First-Pass Effect in Basilar Artery Occlusions: Insights From the Endovascular Treatment of Ischemic Stroke Registry	28
Test Accuracy of the Montreal Cognitive Assessment in Screening for Early Poststroke Neurocognitive Disorder	28
Computed Tomography Perfusion Deficit Volumes Predict Functional Outcome in Patients With Basilar Artery Occlusion	28